Rofecoxib |
Rofecoxib Products |
| After withdrawal of Vioxx, two COX-2 agents remain: rofecoxib linked to thrombotic events.(News): An article from: Internal Medicine News Elizabeth Mechcatie, Peggy Peck International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Rofecoxib may cut risk of lower GI bleeding by 54%: compared with naproxen in study of more than 8,000 rheumatoid arthritis patients. (First Prospective ... An article from: Family Practice News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| NSAIDs for 1 year failed to slow Alzheimer's disease. (Preventive Role Still Possible).(evaluation of rofecoxib and naproxen): An article from: Internal Medicine News Miriam E. Tucker International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Rofecoxib, Montelukast Combo Cut Migraines.(Brief Article): An article from: Family Practice News Sherry Boschert International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| High-dose rofecoxib linked to increased MI risk: observational study data 'cast serious doubt on the safety of rofecoxib' at dosages above 25 mg per day.(Rx)(myocardial ... An article from: Internal Medicine News Nancy Walsh International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Daily rofecoxib linked to rise in blood pressure. (Patients with Diabetes, HT, Osteoarthritis).: An article from: Internal Medicine News Mitchel L. Zoler International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Daily rofecoxib may cause spike in blood pressure. (Patients with Diabetes and Hypertension).(side effects of osteoporosis treatment): An article from: Family Practice News Mitchel L. Zoler International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Rofecoxib approved as rheumatoid arthritis Tx.(News): An article from: Pediatric News Kerri Wachter International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| FDA now reviewing panel's nod to COX-2s: celecoxib garnered nearly unanimous support; vote was more divided on rofecoxib and valdecoxib.(Practice Trends): An article from: Clinical Psychiatry News Elizabeth Mechcatie International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Fewer GI Events With Supertherapeutic Doses of Rofecoxib.: An article from: Family Practice News Betsy Bates International Medical News Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 

